Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Eximore is developing ophthalmic drug-delivery products. The company's initial target is a noninvasive punctal plug designed to release glaucoma drugs, controlled over a long period of time. Eximore's product aims to circumvent the need to apply daily eye drops and thereby improve compliance.